ECP 2023 Final Programme

Sunday, 10 Sept Scientific Programme a Sunday 32 004 09:00–09:10 Is Mandard’s tumour regression score able to assess the response to chemo-radiothera- py in patients with locally advanced cervical cancer? Giulia Scaglione, Italy D. Arciuolo, A. Travaglino, A. Santoro, N. D’Alessandris, M. Valente, G. Angelico, F. Inzani, A. Muccilli, S. Sfregola, B. Padial Urtueta, S. Spadola, L. Pedone Anchora, M. Ferrandina, G. Zannoni 005 09:10–09:20 Mutational profiling of recurrent endometrial endometrioid carcinoma with no specific molecular profile (NSMP)/p53wt using endometrial brush sampling Basile Tessier-Cloutier, Canada A. Khatib, T. Revil, L. Jiang, L. Gilbert 006 09:20–09:30 Proficiency testing of p53 IHC pattern interpretation in vulvar biopsies shows overcalling of the mutant basal overex- pression pattern in TP53 wild-type cases Marilyn Kinloch, Canada C. Parra-Herran, G. Focchi, B. Howitt, S. Skala, S. Strickland, J. Watkins, R. Wong, E. Torlakovic, R. Crawford, B. Gilks, L. Anderson, N. Singh, K. Wei, L. Hoang 007 10:30–10:40 Prognostic impact of pathological parame- ters in molecular subgroups of endometrial carcinoma Antonio De Leo, Italy M. Ruscelli, F. Rosini, A. Corradini, T. Maloberti, S. Coluccelli, A. Costantino, C. Ceccarelli, D. de Biase, D. Santini, G. Tallini 008 10:40–10:50 Endometrial stromal sarcomas with BCOR alterations: clinicopathological and molecular study of a rare subgroup Catarina Alves-Vale, Portugal M. Varela dos Santos, N. Maida Méndez, C. Martins, F. Silva, S. Lérias, A. Felix, J. Ferreira 009 10:50–11:00 Genomic profile analysis of leiomyomas with bizarre nuclei and fumarate hydratase deficient leiomyomas: strengths, weakness- es, and limitations of array-CGH interpreta- tion Quitterie Fontanges, Belgium P. Dubos, T. Lesluyes, Y. Laizet, V. Velasco, L. Mayeur, E. Oliva, R. Young, M. Devouassoux- Shisheboran, S. Isabelle, G. Frédéric, J. Noël, M. Barbara, F. Chibon, S. Croce 010 11:00–11:10 Diagnostic value of pan-TRK immunohisto- chemistry in NTRK-rearranged gynaecolog- ical sarcomas and morphological mimics. A study of 473 gynaecological mesenchymal tumours Sabrina Croce, France M. Souto, V. Velasco, F. Kommos, E. Oliva, I. Treilleux, M. Devouassoux-Shisheboran, I. Hostein, I. Soubeyran, E. Khalifa, G. McCluggage, C. Hartog, F. Le Loarer, J. Costa 011 11:10–11:20 Estrogen receptor expression in endometrial adenocarcinomas of no specific molecular profile shows a bimodal distribution Blake Gilks, Canada L. Hoang, B. Howitt, T. Longacre, J. McAlpine, A. Jamieson, N. Singh, J. Pors 012 11:20–11:30 Cytology evaluation of neuroblastic tumours Eugénia Dvindenko, Portugal F. Santos, M. Lemos 013 11:30–11:40 Application of the new WHO reporting system for lung cytopathology on bronchial wash samples: a cytohistological correlation study from a tertiary hospital Joao Vaz Silva, Portugal L. Leça, C. Lobo, N. Coimbra, A. Cunha, P. Monteiro 014 11:40–11:50 Routine next generation sequencing testing on lung adenocarcinoma pap-stained (OH-fixed) cytological samples Tania Labiano, Spain E. Almudevar, D. Guerrero